XpresSpa Group Board of Directors Elects Chairman
Mar 05, 2018 13:02 pm UTC| Business
NEW YORK, March 05, 2018 -- XpresSpa Group Inc. (Nasdaq:XSPA), a health and wellness holding company, today announced that its Board of Directors has elected Bruce T. Bernstein as Chairman of the Board. Mr. Bernstein...
Summer Infant to Present at the Roth Capital Conference March 12, 2018
Mar 05, 2018 13:02 pm UTC| Business
WOONSOCKET, R.I., March 05, 2018 -- Summer Infant, Inc. ("Summer Infant" or the "Company") (NASDAQ:SUMR), a global leader in premium infant and juvenile products, today announced that it will present at the 30th Annual...
Jounce Therapeutics to Present at Cowen and Company 38th Annual Health Care Conference
Mar 05, 2018 13:02 pm UTC| Business
CAMBRIDGE, Mass., March 05, 2018 -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers for patient...
Golden Predator Commences 2018 Winter Drill Program at 3 Aces Project
Mar 05, 2018 13:02 pm UTC| Business
VANCOUVER, British Columbia, March 05, 2018 -- Golden Predator Mining Corp. (TSX.V:GPY) (OTCQX:NTGSF) (the “Company” or “Golden Predator”) is pleased to announce it has commenced a 4,000 m diamond drill program at its...
Mar 05, 2018 13:02 pm UTC| Business
REHOVOT, Israel, March 05, 2018 -- Todos Medical Ltd. (OTC Pink:TOMDF) (http://www.Todosmedical.com) today announced the initiation of its first blinded clinical trial for TM-B1 – a simple blood test for breast cancer...
Pivot Pharma Closes C$5M Private Placement of Convertible Debentures
Mar 05, 2018 13:02 pm UTC| Business
VANCOUVER, British Columbia, March 05, 2018 -- via NetworkWire – Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB: PVOTF) (“Pivot” or the “Company”) is pleased to announce the closing of its previously announced private...
Avinger Announces Participation in Cowen and Company 38th Annual Health Care Conference
Mar 05, 2018 13:02 pm UTC| Business
REDWOOD CITY, Calif, March 05, 2018 -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the Company will be participating in the Cowen...